Björn Gerlach

ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 8

Top Venues

F1000Research

eLife

Nature reviews. Drug discovery

EMBO reports

PAASP GmbH

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

PAASP GmbH Dec 01 2015

Germany

Partner / COO :: Operations

AbbVie Deutschland GmbH and Co KG Ludwigshafen Jan 01 2013 - Oct 31 2015

Germany

PostDoc :: Neuroplasticity

Abbott (Germany) Nov 01 2011 - Dec 31 2012

Germany

PostDoc :: Neuroplasticity

Education History

Imperial College London Mar 01 2008 - Feb 28 2011

United Kingdom

PHD :: Tumour Immonology

Publications

Anton Bespalov, René Bernard, Anja Gilis, Björn Gerlach, Javier Guillén, Vincent Castagné, Isabel A Lefevre, Fiona Ducrey, Lee Monk, Sandrine Bongiovanni, Bruce Altevogt, María Arroyo-Araujo, Lior Bikovski, Natasja de Bruin, Esmeralda Castaños-Vélez, Alexander Dityatev, Christoph H Emmerich, Raafat Fares, Chantelle Ferland-Beckham, Christelle Froger-Colléaux, Valerie Gailus-Durner, Sabine Maria Hölter, Martine Catharina Josephine Hofmann, Patricia Kabitzke, Martien J H Kas, Claudia Kurreck, Paul Moser, Malgorzata Pietraszek, Piotr Popik, Heidrun Potschka, Ernesto Prado Montes de Oca, Leonardo Restivo, Gernot Riedel, Merel Ritskes-Hoitinga, Janko Samardžić, Michael Schunn, Claudia Stoeger, Vootele Voikar, Jan Vollert, Kimberley Elaine Wever, Kathleen Wuyts, Malcolm Robert MacLeod, Ulrich Dirnagl, Thomas Steckler
Introduction to the EQIPD quality system. eLife 10 (2021)
Leonardo Restivo, Björn Gerlach, Micheal Tsoory, Lior Bikovski, Sylvia Badurek, Claudia Pitzer, Isabelle C Kos-Braun, Anne-Laure Mj Mausset-Bonnefont, Jonathan Ward, Michael Schunn, Lucas Pjj Noldus, Anton Bespalov, Vootele Voikar
Towards best practices in research: Role of academic core facilities. EMBO reports 22 (12) (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Isabelle C Kos-Braun, Björn Gerlach, Claudia Pitzer
A survey of research quality in core facilities. eLife 9 (2020)
Anton Bespalov, Christoph H Emmerich, Björn Gerlach
Enhancing quality in preclinical data: Of hot science and cool quality. Temperature (Austin, Tex.) 7 (4) (2020)
Christoph H Emmerich, Lorena Martinez Gamboa, Martine C J Hofmann, Marc Bonin-Andresen, Olga Arbach, Pascal Schendel, Björn Gerlach, Katja Hempel, Anton Bespalov, Ulrich Dirnagl, Michael J Parnham
Improving target assessment in biomedical research: the GOT-IT recommendations. Nature reviews. Drug discovery 20 (1) (2020)

Björn Gerlach.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Björn Gerlach